candesartan

advanced glycosylation end product-specific receptor ; Mus musculus







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 18594792 The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation. 2008 Sep 1
2 15574998 Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice. 2004 Dec 2